PSMA radioligand therapy (PRLT) of metastatic castration-resistant prostate cancer: first results using the PSMA Inhibitor 617

被引：0
|
作者：
Kulkarni, Harshad [1 ]
Singh, Aviral [1 ]
Niepsch, Karin [1 ]
Schuchardt, Christiane [1 ]
Baum, Richard [1 ]
机构：
[1] Zent Klin Bad Berka, THERANOST Ctr Mol Radiotherapy & Mol Imaging PET, Bad Berka, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
139
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Intermittent Lu-177-PSMA-617 therapy of metastatic castration-resistant prostate cancer in early responders
    Mader, Nicolai
    Ngoc, Christina Nguyen
    Baumgarten, Justus
    Groener, Daniel
    Davis, Karen
    Wichert, Jennifer
    Tselis, Nikolaos
    Mandel, Philipp
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [42] The efficacy and safety of 225Ac-PSMA-617 in metastatic castration-resistant prostate cancer
    Ma, Jiao
    Zhang, Yu
    Yangqing, Jiangchu
    Liu, Guangfu
    Wang, Junzheng
    Zhang, Chunyin
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [43] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [44] [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer
    Derlin, Thorsten
    Schmuck, Sebastian
    LANCET ONCOLOGY, 2018, 19 (08): : E372 - E372
  • [45] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [46] Dosimetry in Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer using Lu-177 Labelled PSMA Small Molecules I&T and 617
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Singh, A.
    Far, M. Shahin
    Langbein, T.
    Lehmann, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S110 - S111
  • [47] Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer
    Rahbar, Kambiz
    Bode, Axel
    Weckesser, Matthias
    Avramovic, Nemanja
    Claesener, Michael
    Stegger, Lars
    Boegemann, Martin
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 522 - 528
  • [48] Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Gutsche, Robin
    Guelmues, Gizem
    Mottaghy, Felix M.
    Gaertner, Florian
    Essler, Markus
    von Mallek, Dirk
    Ahmadzadehfar, Hojjat
    Lohmann, Philipp
    Heinzel, Alexander
    FRONTIERS IN NUCLEAR MEDICINE, 2023, 3
  • [49] Survival outcomes of patients with metastatic castration resistant prostate cancer receiving 225Ac-PSMA-617 radioligand therapy
    Bal, Chandrasekhar
    Ballal, Sanjana
    Yadav, Madhav
    Sahoo, Ranjit
    Tripathi, Madhavi
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [50] Antitumor activity of repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Rahbar, Kambiz
    Braeuer, Axel
    Yordanova, Anna
    Boegemann, Martin
    Hauser, Stefan
    Eveslage, Maria
    Essler, Markus
    Schafers, Michael
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
12345